SCHEMBL19080033

SCHEMBL19080033

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5cc6oc7cc8ccccc8cc7c6c6ccccc56)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.40
ESR2 Q92731 8/20 0.40
GPR84 Q9NQS5 2/20 0.39
CYP1A2 P05177 2/20 0.36
CYP1A1 P04798 1/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
AHR P35869 1/20 0.36
PAX8 Q06710 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
MPI P34949 1/20 0.36
ALOX5 P09917 1/20 0.35
GSTP1 P09211 1/20 0.35
MIF P14174 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080096 0.94 GSTP1 (0.40) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19079984 0.93 GPR84 (0.36) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19079951 0.93 ESR1 (0.43) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19076408 0.90 AHR (0.38) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL17931975 0.89 GPR84 (0.37) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL20363631 0.89 ESR1 (0.44) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19080062 0.88 PSD (0.34) GPR84CYP1A2CYP1A1KDM4EALDH1A1
SCHEMBL19076407 0.88 MAOA (0.37) ESR1ESR2GPR84CYP1A2AHR
SCHEMBL19080030 0.88 ABCG2 (0.46) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL20127352 0.86 GPR84 (0.39) ESR1ESR2GPR84CYP1A2CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885GPR84 2425/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ESR1 153/4885ESR2 510/4885GPR84 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.